BioAge Labs reports positive Phase 1 data for oral NLRP3 inhibitor BGE-102 in people with obesity and elevated inflammation by thaan@22fillmore.com | Apr 21, 2026 | Portfolio News
Opna Bio receives FDA Fast Track designation for OPN-6602 in relapsed or refractory multiple myeloma by thaan@22fillmore.com | Apr 15, 2026 | Portfolio News
Viridian Therapeutics reports positive Phase 3 REVEAL-1 results for elegrobart in active thyroid eye disease by mariel | Mar 30, 2026 | Portfolio News
Kestra Medical Technologies reports third quarter fiscal 2026 results; raises FY2026 revenue guidance to $93M, representing 55% growth vs. FY2025 by mariel | Mar 17, 2026 | Portfolio News
CytomX Therapeutics reports positive Phase 1 data for CX-2051 (Varseta-M) in colorectal cancer by mariel | Mar 16, 2026 | Portfolio News
